Business combinations (Tables)

12 Months Ended

Dec. 31, 2014

Schedule of recognized identified assets acquired and liabilities assumed

The consideration to acquire deCODE, KAI, MN, and Micromet was allocated to the acquisition date fair values of the assets acquired and liabilities assumed as follows (in millions):



	deCODE			KAI			MN			Micromet
IPR&D	$	—		$	240		$	—		$	570
Developed product technology rights	—			—			81			—
R&D technology rights	465			—			—			350
Marketing-related rights	—			—			82			—
Deferred income taxes, net	(37		)	(59		)	(45		)	(191		)
Other assets (liabilities), net	(29		)	26			179			170
Goodwill	—			125			380			247
Total consideration	$	399		$	332		$	677		$	1,146

Onyx Pharmaceuticals, Inc. [Member]

Business Acquisition [Line Items]

Aggregate acquisition date consideration to acquire an entity

The aggregate consideration to acquire Onyx was paid in cash and consisted of (in millions):



Total consideration transferred	$	9,517
Compensation expense	197
Total cash paid	$	9,714

Schedule of recognized identified assets acquired and liabilities assumed

The consideration to acquire Onyx was allocated to the acquisition date fair values of assets acquired and liabilities assumed as follows (in millions):



Cash and cash equivalents	$	319
Marketable securities	337
Inventories	170
Indefinite-lived intangible assets - IPR&D	1,180
Finite-lived intangible assets - Developed product technology rights	6,190
Finite-lived intangible assets - Licensing rights	2,792
Goodwill	2,402
Convertible debt	(742		)
Assumed contingent consideration	(261		)
Deferred income taxes, net	(3,011		)
Other assets (liabilities), net	141
Total consideration	$	9,517

Business acquisition, pro forma information

The following table presents supplemental pro forma information as if the acquisition of Onyx had occurred on January 1, 2012 (in millions, unaudited):



	Years ended December 31,
	2013		2012
Pro forma net revenues	$	19,141	$	17,616
Pro forma net income	4,848		3,700

Product Rights [Member]

Business Acquisition [Line Items]

Aggregate acquisition date consideration to acquire an entity

The aggregate consideration transferred consisted of (in millions):



Total consideration transferred	$	497
Settlement of preexisting relationship at fair value	(99		)
Total consideration transferred to acquire the Product Rights	$	398

Schedule of recognized identified assets acquired and liabilities assumed

The consideration to acquire the Product Rights was allocated to the acquisition date fair values of assets as follows (in millions):



Finite-lived intangible assets - Marketing-related rights	$	363
Finite-lived intangible assets - Developed product technology rights	11
Goodwill	3
Other assets	21
Total consideration	$	398